Screener
AN2 Therapeutics, Inc. ANTX Q1 2026 earnings
Reported May 11, 2026 · Before market open
EPS-$0.29Miss by $0.06
EPS estimate-$0.23
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$0.20
Versus estimates
Diluted EPS
FAQ
- When did AN2 Therapeutics, Inc. report Q1 2026 earnings?
- AN2 Therapeutics, Inc. (ANTX) reported Q1 2026 earnings on May 11, 2026 before market open.
- What were AN2 Therapeutics, Inc.'s Q1 2026 revenue and EPS?
- AN2 Therapeutics, Inc. reported eps of $-0.29 for Q1 2026.
- Did AN2 Therapeutics, Inc. beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-0.23 by $0.06.
- How did AN2 Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 17.1% from $-0.35.
- Where can I find AN2 Therapeutics, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-216752) and the 10-Q periodic report (0001193125-26-216755) directly on SEC EDGAR. The filing index links above go to sec.gov.
